Quantcast

Latest Tumor markers Stories

2014-06-26 08:27:43

- Trial will measure investigational compound's efficacy and safety in patients with HER2-negative breast cancer, associated with BRCA 1, BRCA 2 mutations NORTH CHICAGO, Ill., June 26, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the initiation of a Phase III clinical trial evaluating the safety and efficacy of its investigational compound, veliparib (ABT-888), when added to carboplatin and paclitaxel, two chemotherapeutic medicines, in patients with advanced breast...

2014-06-25 23:14:27

AllMed webinar provides in-depth review of the latest in standard of care for the genetic testing of breast and ovarian cancer. Portland, Oregon (PRWEB) June 25, 2014 Advances in genetic testing technology have improved detection rates for BRCA1 and BRCA2 mutations in individuals who are at high risk for breast and ovarian cancer, but some mutations are missed with standard genetic testing. During a recent AllMed webinar, Dr. Della Howell, board-certified hematologist-oncologist,...

2014-06-11 08:31:25

LONDON, June 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Cancer Diagnostic Testing World Marketshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/cancer_diagnostic_testing_world_markets.html Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten million Americans have or have had some form of cancer. Overall costs...

2014-06-06 08:24:52

Initial clinical experience with 89Zr-labeled anti-PSMA minibody presented LOS ANGELES, June 6, 2014 /PRNewswire/ -- ImaginAb, Inc., in collaboration with Memorial Sloan-Kettering Cancer Center (MKSCC), will be presenting initial clinical data with an anti-PSMA recombinant antibody fragment (a "minibody") derived from the huJ591 monoclonal antibody, in patients with metastatic prostate cancer. The presentation of this initial data coincides with the Company's preparation to expand...

2014-05-27 08:27:46

-- High calibre German consulting company appointed to assist CE Mark registration process SYDNEY, May 27, 2014 /PRNewswire/ -- Australian biotechnology company Minomic International Limited will register its MiStat(TM) ELISA prostate cancer test for CE Mark approval in the latter part of 2014. Achieving CE approval will be a key commercial milestone for the company, allowing it to sell and market its early detection diagnostic technology in the 33 member countries within the...

2014-05-16 12:27:55

The Lipo 7 product is a perfect alternative to the HCG injection product for those preferring vitamins, minerals and amino acids over the hcg injections. NEW HAVEN, Conn., May 16, 2014 /PRNewswire-iReach/ -- Lipotropic Injections are weight loss injections made of natural ingredients like vitamins, minerals and amino acids that assist in metabolizing and burning fats stored in the body. These nutrients are typically given in concentrated doses not typically found in just one meal...

2014-04-24 08:34:08

Beckman Coulter's Prostate Health Index (phi) Available Nationwide for Better Prostate Cancer Detection BREA, Calif., April 24, 2014 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in prostate cancer diagnostics, announces national availability of the Prostate Health Index (phi)*, a simple, non-invasive blood test that is three times more specific in detecting prostate cancer(1) than PSA (prostate-specific antigen). The new test's accuracy decreases the need for many men...

2014-04-18 13:44:32

The presence of chronic inflammation in benign prostate tissue was associated with high-grade, or aggressive, prostate cancer, and this association was found even in those with low prostate-specific antigen (PSA) levels, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. An analysis of prostate tissue biopsies collected from some participants of the placebo arm of the Prostate Cancer Prevention...

2014-04-08 12:30:37

-- Peak US urology organisation CUSP Group, LLC to evaluate MiStat(TM) technology SYDNEY, April 8, 2014 /PRNewswire/ -- Private Australian biotechnology company Minomic International Ltd will launch two overseas trials of its MiStat(TM) prostate cancer screening test, following an agreement with the prestigious CUSP Group, LLC a Uro-Oncology Trials Management Organisation in the United States. An initial pilot study to be launched in April will examine 300 patient samples and is...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related